Table 1—

Patient demographics

Subject no.SexAge yrsHeight cmBaseline FEV1 LBaseline FEV1 % predAllergenAllergen dilution#Methacholine PC20 mg·mL−1Medication
1M601682.4274Grass1:2560.56Salb
2F241553.29106HDM (Dp)1:2562.5Salb
3M301783.4177Cat1:2560.34Salb
4M251804.2591Grass1:641.4Salb
5M241853.4971Grass1:1281.7Salb/Bud
6F471682.4784Cat1:1287.0Salb
7M581803.4490Cat1:1281.3Salb
8F261653.75110HDM (Df)1:6411.7Salb
9M231835.22107Cat1:325.3Salb
10F441733.72122Cat1:45.6Salb/flonase
Mean±sd36.1±14.8173.5±9.73.55±0.8193.2±17.32.27
  • Flonase was given at a dose of 2 squirts·nare−1·day−1. FEV1: forced expiratory volume in 1 s; % pred: % predicted; PC20: provocative concentration of methacholine causing a 20% fall in FEV1; M: male; F: female; HDM: house dust mite; Dp: Dermatophagoides pteronyssinus; Df: Dermatophagoides farinae; Salb: salbutamol p.r.n.; Bud: budesonide 400 μg·day−1. #: final concentration administered; : geometric mean.